Tilray Inc (TLRY) Expected to Announce Earnings of -$0.19 Per Share

Analysts expect Tilray Inc (NASDAQ:TLRY) to post earnings per share (EPS) of ($0.19) for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Tilray’s earnings, with estimates ranging from ($0.33) to ($0.09). The company is expected to issue its next quarterly earnings report on Tuesday, February 12th.

According to Zacks, analysts expect that Tilray will report full year earnings of ($0.63) per share for the current financial year, with EPS estimates ranging from ($0.79) to ($0.51). For the next financial year, analysts expect that the business will post earnings of ($0.55) per share, with EPS estimates ranging from ($1.40) to ($0.12). Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Tilray.

Tilray (NASDAQ:TLRY) last posted its earnings results on Tuesday, November 13th. The company reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.08). The business had revenue of $10.00 million for the quarter, compared to analyst estimates of $10.25 million. Tilray had a negative net margin of 121.22% and a negative return on equity of 60.74%. The business’s revenue for the quarter was up 85.2% on a year-over-year basis.

A number of equities analysts have commented on the stock. Zacks Investment Research lowered shares of Tilray from a “hold” rating to a “sell” rating in a report on Thursday, December 20th. Roth Capital reiterated a “neutral” rating on shares of Tilray in a report on Tuesday, October 2nd. Piper Jaffray Companies assumed coverage on shares of Tilray in a report on Wednesday. They issued an “overweight” rating and a $90.00 price objective on the stock. Benchmark assumed coverage on shares of Tilray in a report on Tuesday, October 16th. They issued a “buy” rating and a $200.00 price objective on the stock. Finally, Cowen boosted their price objective on shares of Tilray from $62.00 to $172.00 and gave the stock an “outperform” rating in a report on Tuesday, October 9th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $124.25.

A number of hedge funds have recently modified their holdings of the business. Captrust Financial Advisors acquired a new position in Tilray in the 3rd quarter worth $103,000. IFP Advisors Inc acquired a new position in Tilray in the 3rd quarter worth $154,000. G&S Capital LLC acquired a new position in Tilray in the 3rd quarter worth $155,000. Independent Advisor Alliance acquired a new position in Tilray in the 3rd quarter worth $216,000. Finally, Raging Capital Management LLC acquired a new position in Tilray in the 3rd quarter worth $215,000. Hedge funds and other institutional investors own 6.08% of the company’s stock.

NASDAQ:TLRY opened at $96.00 on Friday. The company has a current ratio of 5.43, a quick ratio of 4.98 and a debt-to-equity ratio of 0.05. Tilray has a twelve month low of $20.10 and a twelve month high of $300.00.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

Featured Story: How is the S&P 500 index different from the DJIA?

Get a free copy of the Zacks research report on Tilray (TLRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit